Kirn, I have done search on PubMed for Navin Thapa and there are atleast 9 publications, probably not all by him but not bad for Nepalese scholars. And he is mentioned on the www.vaccine.ac.uk as a researcher in a $1.3 miilion grant from the Gates Grand Challenges in Gobal Health Initiative: Live Oral BCG Moreau Rio de Janeiro Vaccine as model of gut innate immunity and infection Prof David Lewis and Professor Gordon Dougan of the Wellcome Trust Sanger Genome Campus have received a $1.3 million grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative to conduct a programme of research to apply the Brazilian strain of BCG (Moreau) as a model of gut innate immunity, in collaboration with researchers in Ecuador (Dr Phil Cooper) and Nepal (Dr Navin Thapa), together with studies of typhoid in Vietnam (Principal Invetigator Dr. J Farrar). This is part of a grant to Principal Investigator Dr. Brett Finlay, University of British Columbia, Canada, A series of clinical studies enrolling 50-75 healthy volunteers, to commence in Q1 2006, will use the oral delivery of BCG Moreau RdJ to mimic natural infection and to understand why oral vaccines do not always work as well in developing counties as in Northern regions. It is hoped these studies will unlock the key innate immune functions using biomics, and in collaboration with the Wellcome field site in Vietnam (lead by Dr J Farrar), will address these issues in relation to typhoid fever. Other studies will recruit patients with tuberculosis in the UK and abroad.